Registry Strategy Boosts Parkinsonism Research Enrollment
A new recruitment model helps ensure that clinical trials better represent the diversity of the patient population.
Updated on Oct. 27, 2026 in Alzheimer’s
Live Poll
Should medical researchers implement targeted strategies to ensure diversity in clinical trial participation?
A registry-based approach at the James J Peters Veterans Affairs Medical Center successfully increased representative enrollment in parkinsonism clinical trials. Published on September 11, 2026, the strategy improved participation across diverse racial and ethnic groups.
Why it matters
Researchers developed this method to address long-standing selection bias in clinical research, ensuring that trial cohorts better reflect the broader patient population. This approach aims to improve the generalizability of study findings for all patients with degenerative parkinsonism.
This retrospective analysis reviewed 192 patients with degenerative parkinsonism, with a median age of 76 years. The study team reports that their registry-based approach achieved an 80.5% acceptance rate among those invited to participate in the CANPARK study.
The players
James J Peters Veterans Affairs Medical Center
A facility providing comprehensive health care and movement disorder services to veterans.
Department of Veterans Affairs
The federal agency overseeing veterans health care and supporting clinical research initiatives.
American Parkinson Disease Association
An organization focused on providing support, education, and funding for research into Parkinson disease.
The details
The recruitment model utilizes a real-time standard-of-care registry to identify patients based on demographic and clinical eligibility. To minimize barriers, the program integrated flexible protocols and bilingual staff, while coordinating research procedures directly with routine clinical appointments. Additional support measures, such as providing transportation, helped ensure that patients with varying levels of mobility or social support could successfully enroll.
Timeline
December 2022: Study data collection began.
June 2024: Study data collection concluded.
September 11, 2026: Findings were published.
Health Landscape
This initiative follows the ongoing national movement to ensure that clinical research cohorts accurately represent the diversity of the patient population. By addressing logistical barriers at the point of care, the study seeks to evolve beyond historical recruitment challenges in movement disorders.
If you are managing parkinsonism, it is worth asking your specialist if your clinic participates in research registries that facilitate trial access. Discussing the potential for clinical study participation with your neurologist can ensure you are informed of options that may be a good fit for your care.
The takeaway
Registry-based recruitment strategies can significantly lower barriers to participating in movement disorder research. When considering clinical trials, feel free to talk with your physician about available local studies and the support services they provide to make participation more accessible.
Further reading
For more information on current treatment trends, visit our Alzheimer’s section.
Source note: This article includes information reported by Neurology Advisor.
Live Poll
Should medical researchers implement targeted strategies to ensure diversity in clinical trial participation?
